Intranasally administered S-MGB-364 displays antitubercular activity and modulates the host immune response to Mycobacterium tuberculosis infection (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/jac/dkac001
PubMed Identifier: 35084027
Publication URI: http://europepmc.org/abstract/MED/35084027
Type: Journal Article/Review
Parent Publication: Journal of Antimicrobial Chemotherapy
Issue: 4
ISSN: 0305-7453